Carl Walkey - Net Worth and Insider Trading
Carl Walkey Net Worth
The estimated net worth of Carl Walkey is at least $236,008 dollars as of 2024-06-05. Carl Walkey is the Senior Vice President of Neoleukin Therapeutics Inc and owns about 67,624 shares of Neoleukin Therapeutics Inc (NLTX) stock worth over $236,008. Details can be seen in Carl Walkey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Carl Walkey has not made any transactions after 2021-06-16 and currently still holds the listed stock(s).
Transaction Summary of Carl Walkey
Carl Walkey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carl Walkey owns 1 companies in total, including Neoleukin Therapeutics Inc (NLTX) .
Click here to see the complete history of Carl Walkey’s form 4 insider trades.
Insider Ownership Summary of Carl Walkey
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NLTX | Neoleukin Therapeutics Inc | 2021-06-16 | Senior Vice President |
Carl Walkey Latest Holdings Summary
Carl Walkey currently owns a total of 1 stock. Carl Walkey owns 67,624 shares of Neoleukin Therapeutics Inc (NLTX) as of June 16, 2021, with a value of $236,008.
Latest Holdings of Carl Walkey
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NLTX | Neoleukin Therapeutics Inc | 2021-06-16 | 67,624 | 3.49 | 236,008 |
Holding Weightings of Carl Walkey
Carl Walkey Form 4 Trading Tracker
According to the SEC Form 4 filings, Carl Walkey has made a total of 21 transactions in Neoleukin Therapeutics Inc (NLTX) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in Neoleukin Therapeutics Inc is the sale of 30 shares on June 16, 2021, which brought Carl Walkey around $6,114.
Insider Trading History of Carl Walkey
- 1
Carl Walkey Trading Performance
Carl Walkey Ownership Network
Carl Walkey Owned Company Details
What does Neoleukin Therapeutics Inc do?
Who are the key executives at Neoleukin Therapeutics Inc?
Carl Walkey is the Senior Vice President of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .
Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary
Over the past 18 months, Carl Walkey made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net sale of 18,149 shares made by Priti Patel , a net sale of 4,639 shares made by Sean Michael Smith , and a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp .
In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,139 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 113,128 shares.
Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neoleukin Therapeutics Inc Insider Transactions
Carl Walkey Mailing Address
Above is the net worth, insider trading, and ownership report for Carl Walkey. You might contact Carl Walkey via mailing address: C/o Neoleukin Therapeutics, Inc., 360-1616 Eastlake Avenue East, Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
